SMi will be holding
its 16th annual Generics and Patent Strategies conference from May 13-14, 2013
in London, UK.  The conference will allow
attendees to:

• Discover ways in
which to create a value added product with a view to strategic market entry;
• Discuss the
challenges of creating a value added product;
• Consider how
different markets impact upon the sales of generic drugs;
• Assess the future
of generics and what challenges the future holds; and
• Develop
alternative routes to market, including whether biosimilars or branded products
are the answer.

In particular, SMi
faculty will offer presentations on the following topics:

• Moving into new
markets: Industry trends;
• The allure of generics for big pharma;
• Recent developments in antitrust enforcement in the pharma sector;
• Strategic regulatory affairs and your options in Europe;
• Panel discussion:
Should generics be looking to biosimilars?
• Complex generics, chemisimilars and biosimilars: When is clinical testing adequate?
• Value added generics: Assessing the market;
• Recent case law related
to European patents and Supplementary Protection Certificates for
pharmaceutical products (SPCs);
• Branded generics: Employing commercial strategy;
• Do branded
generics make a difference?
• Generics in
Europe . . . the beginning or the end?
• Preliminary
Injunctions in generics/brand cases;
• Pricing pressures
faced by the industry today;
• Navigating IP challenges;
• Generics: Drug
use and pharmacoeconomics in the Dutch situation; and
• Using patent
litigation to achieve a first-to-launch generic.

A post-conference
workshop, entitled "Pharmacovigilance for Generics: What you need to know,"
will be offered on May 15, 2013.

A complete brochure
for this conference, including an agenda, list of speakers, detailed
descriptions of conference sessions, and registration form can be downloaded
here.  The registration
fee is £1798.80
(conference alone), £2517.60 (conference and workshop), or £718.80 (workshop
alone).  Those interested in registering for the
conference can do so here.

Patent Docs is a media partner of SMi's Generics and Patent Strategies
conference.